IDR 2600.0
(-1.52%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 277.20 IDR | -30.07% |
2022 | 396.42 IDR | -40.37% |
2021 | 664.78 IDR | 131.91% |
2020 | 286.66 IDR | 27.81% |
2019 | 224.28 IDR | 19.84% |
2018 | 187.15 IDR | 16.35% |
2017 | 160.85 IDR | 38.84% |
2016 | 115.85 IDR | 84.01% |
2015 | 62.96 IDR | 0.8% |
2014 | 62.46 IDR | -4.93% |
2013 | 65.70 IDR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | 41.65 IDR | 61.37% |
2024 Q3 | 83.97 IDR | 2.45% |
2024 Q2 | 81.73 IDR | 96.23% |
2023 Q2 | 82.51 IDR | 8.3% |
2023 Q1 | 76.19 IDR | -25.94% |
2023 FY | - IDR | -30.07% |
2023 Q4 | 25.81 IDR | -72.15% |
2023 Q3 | 92.69 IDR | 12.34% |
2022 Q2 | 58.20 IDR | -48.15% |
2022 Q1 | 112.24 IDR | -4.81% |
2022 FY | - IDR | -40.37% |
2022 Q3 | 123.11 IDR | 111.53% |
2022 Q4 | 102.87 IDR | -16.44% |
2021 Q2 | 151.76 IDR | -10.38% |
2021 Q3 | 224.07 IDR | 47.65% |
2021 Q4 | 117.91 IDR | -47.38% |
2021 FY | - IDR | 131.91% |
2021 Q1 | 169.33 IDR | 8.39% |
2020 Q4 | 156.23 IDR | 9.0% |
2020 Q1 | 37.10 IDR | -61.05% |
2020 Q2 | -50.00 IDR | -234.77% |
2020 Q3 | 143.33 IDR | 386.66% |
2020 FY | - IDR | 27.81% |
2019 Q3 | 41.90 IDR | 16.45% |
2019 Q4 | 95.24 IDR | 127.3% |
2019 Q2 | 35.98 IDR | -29.67% |
2019 Q1 | 51.16 IDR | -30.44% |
2019 FY | - IDR | 19.84% |
2018 Q4 | 73.55 IDR | 51.09% |
2018 Q3 | 48.68 IDR | 60.98% |
2018 Q2 | 30.24 IDR | -12.78% |
2018 Q1 | 34.67 IDR | -37.36% |
2018 FY | - IDR | 16.35% |
2017 Q4 | 55.35 IDR | 29.2% |
2017 FY | - IDR | 38.84% |
2017 Q3 | 42.84 IDR | 51.91% |
2017 Q2 | 28.20 IDR | -18.17% |
2017 Q1 | 34.46 IDR | -45.17% |
2016 Q1 | 25.77 IDR | 43.81% |
2016 Q2 | 15.93 IDR | -38.18% |
2016 Q3 | -10.53 IDR | -166.1% |
2016 Q4 | 62.85 IDR | 696.87% |
2016 FY | - IDR | 84.01% |
2015 Q2 | 21.43 IDR | 0.0% |
2015 Q4 | 17.92 IDR | 0.0% |
2015 FY | - IDR | 0.8% |
2015 Q1 | 21.43 IDR | 0.0% |
2015 Q3 | 17.92 IDR | -16.38% |
2014 FY | - IDR | -4.93% |
2013 FY | - IDR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
PT Diagnos Laboratorium Utama Tbk | -10.92 IDR | 2638.462% |